The complex pathogenesis of bacteremia: From antimicrobial clearance mechanisms to the genetic background of the host
dc.contributor.author | Christaki, Eirini | en |
dc.contributor.author | Giamarellos-Bourboulis, Evangelos J. | en |
dc.creator | Christaki, Eirini | en |
dc.creator | Giamarellos-Bourboulis, Evangelos J. | en |
dc.date.accessioned | 2018-06-22T09:52:49Z | |
dc.date.available | 2018-06-22T09:52:49Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41528 | |
dc.description.abstract | Bacteremia develops when bacteria manage to escape the host immune mechanisms or when the otherwise well-orchestrated immune response fails to control bacterial spread due to inherent or acquired immune defects that are associated with susceptibility to infection.the pathogenesis of bacteremia has some characteristic features that are influenced by the genetic signature of the host.in this review, the host defense mechanisms that help prevent bacteremia will be described and the populations who are at risk because of congenital or acquired deficiencies in such mechanisms will be defined. A special mention will be made to novel insights regarding host immune defense against the most commonly isolated organisms from patients with community-acquired bloodstream infections. © 2014 Landes Bioscience. | en |
dc.language.iso | eng | en |
dc.source | Virulence | en |
dc.subject | Human | en |
dc.subject | Humans | en |
dc.subject | Review | en |
dc.subject | Unindexed drug | en |
dc.subject | Gamma interferon | en |
dc.subject | Sepsis | en |
dc.subject | Meta analysis (topic) | en |
dc.subject | Genetic susceptibility | en |
dc.subject | Genetic predisposition to disease | en |
dc.subject | Pathogenesis | en |
dc.subject | Receptors | en |
dc.subject | Risk | en |
dc.subject | Randomized controlled trial (topic) | en |
dc.subject | C reactive protein | en |
dc.subject | Immunoglobulin enhancer binding protein | en |
dc.subject | Interleukin 1beta | en |
dc.subject | Interleukin 8 | en |
dc.subject | Lipid peroxidation | en |
dc.subject | Nonhuman | en |
dc.subject | Reactive oxygen metabolite | en |
dc.subject | Interleukin 2 | en |
dc.subject | Adaptive immunity | en |
dc.subject | Apoptosis | en |
dc.subject | Immune response | en |
dc.subject | Immunity | en |
dc.subject | Innate | en |
dc.subject | Innate immunity | en |
dc.subject | Genetics | en |
dc.subject | Single nucleotide polymorphism | en |
dc.subject | Anti-infective agents | en |
dc.subject | Antigen presentation | en |
dc.subject | Bacteremia | en |
dc.subject | Bacteria | en |
dc.subject | Bacterial clearance | en |
dc.subject | Binding affinity | en |
dc.subject | Bloodstream infection | en |
dc.subject | Calgranulin | en |
dc.subject | Caspase recruitment domain protein 15 | en |
dc.subject | Communicable disease | en |
dc.subject | Complement component c1q | en |
dc.subject | Complement component c3 | en |
dc.subject | Complement component c4b binding protein | en |
dc.subject | Complement system proteins | en |
dc.subject | Granulocyte chemotactic protein 2 | en |
dc.subject | Host defense | en |
dc.subject | Host-pathogen interactions | en |
dc.subject | Inflammasome | en |
dc.subject | Interleukin 4 | en |
dc.subject | Leukotriene b4 | en |
dc.subject | Lipopolysaccharide | en |
dc.subject | Liver function | en |
dc.subject | Major histocompatibility antigen class 1 | en |
dc.subject | Major histocompatibility antigen class 2 | en |
dc.subject | Mannose binding lectin | en |
dc.subject | Myeloid differentiation factor 88 | en |
dc.subject | Neutrophil | en |
dc.subject | Neutrophil extracellular trap | en |
dc.subject | Nucleotide binding oligomerization domain like receptor | en |
dc.subject | Pattern recognition | en |
dc.subject | Pattern recognition receptor | en |
dc.subject | Peptidoglycan | en |
dc.subject | Phagocytosis | en |
dc.subject | Retinoic acid inducible protein i | en |
dc.subject | Skin | en |
dc.subject | Spleen | en |
dc.subject | Toll like receptor 2 | en |
dc.subject | Toll like receptor 4 | en |
dc.subject | Transcription factor nrf2 | en |
dc.subject | Tumor necrosis factor alpha | en |
dc.title | The complex pathogenesis of bacteremia: From antimicrobial clearance mechanisms to the genetic background of the host | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.4161/viru.26514 | |
dc.description.volume | 5 | |
dc.description.issue | 1 | |
dc.description.startingpage | 57 | |
dc.description.endingpage | 65 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Christaki, Eirini [0000-0002-8152-6367] | |
dc.contributor.orcid | Giamarellos-Bourboulis, Evangelos J. [0000-0003-4713-3911] | |
dc.gnosis.orcid | 0000-0002-8152-6367|0000-0003-4713-3911 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |